Therefore, the aim of this study was to determine whether E2 and P4 treatment influences gastric nNOS/Nrf2 and cellular protein targets in addition to NO-mediated gastric motility and GE after chronic ovariectomy and obesity-induced T2DM in mice. This evidence concerns the gene NFE2L2 and type 2 diabetes mellitus.